BEAM BEAM THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Agreement with Jefferies LLC Beam Therapeutics Inc. has entered into an agreement with Jefferies LLC to offer and sell shares of its common stock, with aggregate sales proceeds of up to $800 million, and has already sold shares with an aggregate offering price of approximately $772.8 million.Get access to all SEC 8-K filings of the BEAM THERAPEUTICS INC